Ansell Ltd
ANN: XASX (AUS)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| @#? | LOCK|@G | LOCK|J<>@f^fp |
Mix Shift to Higher-Margin Healthcare Sales Underpins EBIT Margin Growth
Business Strategy and Outlook
Ansell’s strategic focus is on growing market share in niche markets across industrial and healthcare settings. We think this strategy is appropriate, given a less competitive environment in niche markets, where product innovation and regulatory requirements raise barriers to entry, and an ability to achieve better margins from these sales.
